Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Chang-Ju Qu · SciRah

Researcher profile · Semantic Scholar

Chang-Ju Qu

Share profile

Chang-Ju Qu — researcher profile on SciRah

h-index: 16
Works: 54
Citations: 1,190

Most-cited papers

MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN
Chang-Ju Qu, Zhihui Liang, Jialing Huang, Rui-Ying Zhao +6 more
2012Cell Cycle191 citations Open access
Semantic Scholar
ABCG2 is a Direct Transcriptional Target of Hedgehog Signaling and Involved in Stroma-Induced Drug Tolerance in Diffuse Large B-Cell Lymphoma
Rajesh R. Singh, K. Kunkalla, Chang-Ju Qu, E. Schlette +3 more
2011Oncogene160 citations Open access
Semantic Scholar
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Qing-Ya Cui, Chongsheng Qian, Nan Xu, Li-Qing Kang +13 more
2021Journal of Hematology & Oncology117 citations Open access
Semantic Scholar
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.
Rui-Ying Zhao, S. Yeung, Jing Chen, T. Iwakuma +18 more
2011Journal of Clinical Investigation105 citations Open access
Semantic Scholar
Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden
Chang-Ju Qu, N. Ping, Li-Qing Kang, Hai-Ling Liu +11 more
2020Journal of immunotherapy87 citations
Semantic Scholar
14-3-3σ exerts tumor suppressor activity mediated by regulation of COP1 stability
Chun-Hui Su, Rui-Ying Zhao, Fanmao Zhang, Chang-Ju Qu +8 more
2010Cancer Research55 citations Open access
Semantic Scholar
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells
Jingwen Tan, Yu-Jie Jia, Mei-Xia Zhou, C. Fu +23 more
2022Journal of Hematology & Oncology40 citations Open access
Semantic Scholar
Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma.
Chang-Ju Qu, Ya-Dong Liu, K. Kunkalla, Rajesh R. Singh +4 more
2013Blood40 citations Open access
Semantic Scholar
Transcriptional Regulation of Serine/Threonine Protein Kinase (AKT) Genes by Glioma-associated Oncogene Homolog 1*
N. Agarwal, Chang-Ju Qu, Kranthi Kunkulla, Ya-Dong Liu +1 more
2013Journal of Biological Chemistry38 citations Open access
Semantic Scholar
Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients
Chang-Ju Qu, R. Zou, Peng Wang, Qian Zhu +8 more
2022Frontiers in Immunology36 citations Open access
Semantic Scholar
Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia
Yun-Ju Ma, Chang-Ju Qu, Hai-Ping Dai, Jia Yin +10 more
2019Bone Marrow Transplantation34 citations Open access
Semantic Scholar
Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphoma.
Caixia Li, Ying Zhang, Changfeng Zhang, Jia Chen +17 more
2019JCI Insight25 citations Open access
Semantic Scholar
Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation
Xiao-Wen Tang, B. Valdez, Yun-Ju Ma, Qianqian Zhang +11 more
2021Bone Marrow Transplantation24 citations
Semantic Scholar
Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma
N. Ping, Chang-Ju Qu, Meng-Yun Li, Li-Qing Kang +9 more
2021Annals of Translational Medicine23 citations Open access
Semantic Scholar
Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory Primary Central Nervous System Lymphoma Patient
Rui Zou, Xiaoping Zhou, Hai-Ling Liu, Peng Wang +6 more
2023Cancer research and treatment : official journal of Korean Cancer Association18 citations Open access
Semantic Scholar
DNA Damage-Mediated c-Myc Degradation Requires 14-3-3 Sigma
Yu-ye Wen, Ping-Chieh Chou, L. Phan, Chun-Hui Su +11 more
201318 citations
Semantic Scholar
Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes
Shan-Hao Tang, Hongjie Shen, Chang-Ju Qu, Hai-Ping Dai +6 more
2018Bone Marrow Transplantation15 citations
Semantic Scholar
Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53 alterations
Chang-Ju Qu, Yao-Hua Song, Jia Yin, Yun-Ju Ma +7 more
2021Bone Marrow Transplantation14 citations
Semantic Scholar
A new cyclooxygenase-2 inhibitor, (1E,4E)-1,5-bis(2-bromophenyl)penta-1,4-dien-3-one (GL63) suppresses cyclooxygenase-2 gene expression in human lung epithelial cancer cells: coupled mRNA stabilization and posttranscriptional inhibition.
Jian Xiao, Yi Tan, Yun-Bao Pan, G. Liang +5 more
2010Biological and Pharmaceutical Bulletin14 citations Open access
Semantic Scholar
Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells
Chang-Ju Qu, Zheng Li, Li-Qing Kang, Ying Wang +13 more
2019Bone Marrow Transplantation13 citations Open access
Semantic Scholar
Functional Inhibition of BCL2 is Needed to Increase the Susceptibility to Apoptosis to SMO Inhibitors in Diffuse Large B-Cell Lymphoma of Germinal Center Subtype
K. Kunkalla, Ya-Dong Liu, Chang-Ju Qu, V. Leventaki +3 more
2013Annals of Hematology13 citations Open access
Semantic Scholar
Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology.
Chang-Ju Qu, K. Kunkalla, A. Vaghefi, J. Frederiksen +8 more
2018Cancer Letters12 citations
Semantic Scholar
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center
Dan-Qing Kong, N. Ping, Xinrong Gao, R. Zou +4 more
2023Frontiers in Immunology11 citations Open access
Semantic Scholar
Tandem CAR T Cells Targeting CD19 and CD22 Is a Safe and Highly Efficacious Treatment for Relapse/ Refractory ALL Patients
Xiao-Wen Tang, Li-Qing Kang, Wei Qi, W. Cui +8 more
2019Blood8 citations Open access
Semantic Scholar
Successful chimeric antigen receptor T cell therapy in a case of primary testicular diffuse large-B-cell lymphoma with central nervous system progression
N. Ping, Chang-Ju Qu, Lian Bai, Li-Qing Kang +7 more
2019Leukemia and Lymphoma8 citations
Semantic Scholar
Donor origin CAR19 T cell infusion for B‐ALL relapsed after allogeneic hematopoietic stem cell transplantation
Xiao-Fei Yang, Hai-Ping Dai, Li-Qing Kang, Chang-Ju Qu +11 more
2019Hematological Oncology8 citations
Semantic Scholar
Defining Causative Factors Contributing in the Activation of Hedgehog Signaling in Diffuse Large B-Cell Lymphoma
Elisa Ramírez, Rajesh R. Singh, K. Kunkalla, Ya-Dong Liu +11 more
2012Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis8 citations Open access
Semantic Scholar
Dual epigenetic agents plus rituximab–gemcitabine–oxaliplatin as salvage treatment in relapsed/refractory diffuse large B‐cell lymphoma patients failure of salvage chemotherapy
Chang-Ju Qu, N. Ping, Dan-Qing Kong, Aining Liu +5 more
2022Hematological Oncology6 citations
Semantic Scholar
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma
Lihong Zhang, Haifei Yang, Chongsheng Qian, Ji-Hao Zhou +12 more
2022Hematology6 citations Open access
Semantic Scholar
Multiple blood parameters may serve as a warning to immunochemotherapy-related interstitial lung disease in B-cell lymphoma.
F. Xia, Hai-Ling Liu, Haizhou Zhang, N. Ping +4 more
2021Annals of Palliative Medicine6 citations Open access
Semantic Scholar
CAR‐T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease
Dan-Qing Kong, Chang-Ju Qu, Hai-Ping Dai, Zheng Li +8 more
2020British Journal of Haematology6 citations Open access
Semantic Scholar
Radiotherapy Priming Chimeric Antigen Receptor T Cell Therapy Is a Safe and Promising Approach in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with High Tumor Burden
Chang-Ju Qu, N. Ping, Qian Wu, Li-Qing Kang +4 more
2018Blood5 citations Open access
Semantic Scholar
14-3-3 s Exerts Tumor-Suppressor Activity Mediated by Regulation of COP1 Stability
Chun-Hui Su, Rui-Ying Zhao, Fanmao Zhang, Chang-Ju Qu +8 more
20115 citations
Semantic Scholar
Zr Study: A Prospective Phase II Study of Zanubrutinib-Rituximab Chemo-Free Therapy with or without Autologous Stem Cell Transplantation in Newly Diagnosed Mantle Cell Lymphoma
Chang-Ju Qu, N. Ping, Rui Zou, Jiajie He +6 more
2023Blood3 citations Open access
Semantic Scholar
Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review
Jiajie He, Rui Zou, Li-Qing Kang, Ling-Zi Yu +6 more
2023Frontiers in Oncology3 citations Open access
Semantic Scholar
Successful Treatment of Chimeric Antigen Receptor T Cell Therapy in Refractory or Relapsed Acute Leukemia Patients with TP53 alterations
Chang-Ju Qu, Jia Yin, Li-Qing Kang, Zheng Li +5 more
2019Blood3 citations Open access
Semantic Scholar
Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients
Chang-Ju Qu, N. Ping, Dan-Qing Kong, F. Xia +2 more
2019Blood3 citations
Semantic Scholar
Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1.
N. Agarwal, Chang-Ju Qu, K. Kunkalla, Ya-Dong Liu +1 more
2013Journal of Biological Chemistry3 citations Open access
Semantic Scholar
Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
Min Hu, Yiduo Ding, Haizhou Zhang, W. Guo +4 more
2023Frontiers in Pharmacology2 citations Open access
Semantic Scholar
Decitabine in Combination with Fludarabine and Cyclophosphamide As Lymphodepletion Regimen Followed By CD19/CD22 Bispecific Targeted CAR-T Therapy Significantly Improves Survival in Relapsed/Refractory B-ALL Patients: A Pilot Study
Yun-Ju Ma, Chang-Ju Qu, Hai-Ping Dai, Sining Liu +10 more
2021Blood2 citations Open access
Semantic Scholar
Addition of Chidamide to a Sandwich Protocol, Pegaspargase, Gemcitabine and Oxaliplatin Chemotherapy Combined with Radiotherapy, As First-Line Treatment in Early Stage NK/T-Cell Lymphoma: Real World Outcomes in a Retrospective Study
F. Xia, N. Ping, Qi Bao, Rui Zou +5 more
2023Blood1 citations Open access
Semantic Scholar
Comparison of CART 19 and autologous stem cell transplantation for refractory / relapsed non-Hodgkin ’ s lymphoma
Caixia Li, Ying Zhang, Changfeng Zhang, Jia Chen +17 more
20191 citations
Semantic Scholar
Smoothened (SMO) Is an Adaptor Protein That Recruits TRAF6 and Phospholipase C Gamma 2 (PLCg2) to Enhance the Activation of NF-Kb Signaling Pathway
N. Agarwal, C. Kim, K. Kunkalla, G. Yang +4 more
20151 citations
Semantic Scholar
Abstract 4114: Trimeric G protein-CARMA1 axis links smoothened to NF-κB activation in diffuse large B-cell lymphoma.
Chang-Ju Qu, Ya-Dong Liu, K. Kunkalla, Rajesh R. Singh +4 more
20131 citations
Semantic Scholar
GLI1 Directly Regulates the Transcription of AKT Genes in Diffuse Large B-Cell Lymphoma.
N. Agarwal, Chang-Ju Qu, K. Kunkalla, Ya-Dong Liu +1 more
20121 citations
Semantic Scholar
Smoothened (SMO) Activates NF-Kb Pathway Through Activation of PKCβ/CARMA1 and TRAF6 Stabilization in Diffuse Large B-Cell Lymphoma
Chang-Ju Qu, Ya-Dong Liu, K. Kunkalla, N. Agarwal +1 more
20121 citations
Semantic Scholar
The t(14;18)(q32;q21) Confers Resistance to Apoptosis-Induced by Smoothened Inhibitors In Diffuse Large B-Cell Lymphoma That Can Be Restored by Functional Inhibition of BCL2
K. Kunkalla, Chang-Ju Qu, Ya-Dong Liu, Rajesh R. Singh +1 more
20111 citations
Semantic Scholar
Pomalidomide, Rituximab, Orelabrutinib, and Minichop-like (PRO-miniCHOP) in Elderly Patients with Newly Diagnosed Diffuse Large-B Cell Lymphoma: Preliminary Results from a Phase II Study
N. Ping, Chang-Ju Qu, Jiajie He, Hailing Liu +5 more
2023Blood0 citations Open access
Semantic Scholar
Research on the New Models and New Methods of Senior Corporate Management Training
Jing-Ping Wang, Chang-Ju Qu, Xiao-Xi Cui
20140 citations Open access
Semantic Scholar
Transcriptional Regulation of Serine/Threonine Protein Kinase ( AKT) Genes by Glioma-Associated Oncogene Homolog 1*
N. Agarwal, Chang-Ju Qu, Kranthi Kunkulla, Ya-Dong Liu +1 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

De-Pei Wu×24
Invite
De-Pei Wu — researcher profile on SciRah
Zheng-Ming Jin×19
Invite
Zheng-Ming Jin — researcher profile on SciRah
Li-Qing Kang×18
Invite
Li-Qing Kang — researcher profile on SciRah
Lei Yu×17
Invite
Lei Yu — researcher profile on SciRah

×13

Invite

F. Vega — researcher profile on SciRah

Xiao-Wen Tang×12

Invite

Xiao-Wen Tang — researcher profile on SciRah

Invite

N. Ping — researcher profile on SciRah

Ya-Dong Liu×12

Invite

Ya-Dong Liu — researcher profile on SciRah

K. Kunkalla×11

Invite

K. Kunkalla — researcher profile on SciRah

Hai-Ping Dai×11

Invite

Hai-Ping Dai — researcher profile on SciRah

Invite

F. Xia — researcher profile on SciRah

Invite

Jia Yin — researcher profile on SciRah